This federal contract award, with an ID of SPE2DB22D3016|SPE2DB25FAHS7, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is a Delivery Order with a Firm Fixed Price pricing type, is for the supply of DAPAGLIFLOZIN 10 MG TABLET 30S, a medication used to manage diabetes. The contract has a ceiling value of $8,498.88 and an ultimate completion date of December 31, 2024.
Amerisourcebergen Drug Corp is a for-profit organization registered in the System for Award Management (SAM.gov) and has established itself as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Generated 4/1/25, 3:43 PM